Bolt Biotherapeutics, Inc.
BOLT
$3.68
-$0.18-4.71%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -7.72M | -7.24M | -6.63M | -7.14M | -8.56M |
| Total Depreciation and Amortization | 171.00K | 203.00K | 255.00K | 290.00K | 347.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.59M | 1.14M | 1.53M | 913.00K | 1.08M |
| Change in Net Operating Assets | -582.00K | -2.12M | -2.31M | -3.79M | -2.46M |
| Cash from Operations | -6.54M | -8.02M | -7.16M | -9.73M | -9.60M |
| Capital Expenditure | -13.00K | -- | 0.00 | -72.00K | -- |
| Sale of Property, Plant, and Equipment | 686.00K | 31.00K | 0.00 | 0.00 | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 7.10M | 7.89M | 1.07M | 17.96M | 10.79M |
| Cash from Investing | 7.77M | 7.92M | 1.07M | 17.88M | 10.79M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 19.00K | 6.00K | 5.00K | 0.00 | 14.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 19.00K | 6.00K | 5.00K | 0.00 | 14.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.25M | -94.00K | -6.08M | 8.15M | 1.21M |